Global Molecular Diagnostic
Market Report
2024
Molecular Diagnostic Market Report 2024 (Global Edition)
The Molecular Diagnostics Market was valued at USD 23.5 billion in 2022 and will reach USD 36.06 billion by 2030, registering a CAGR of 5.5% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Molecular Diagnostic Market Report 2024.
Global Molecular Diagnostic Market Report 2024 Market Size Split by Product (Instruments, Reagents, Software & Services), by Application (Infectious Disease, Oncology, Genetic Testing, Blood Screening...
The Molecular Diagnostics Market was valued at USD 23.5 billion in 2022 and will reach USD 36.06 billion by 2030, registering a CAGR of 5.5% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Molecular Diagnostic Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.5% |
| Market Split by Product |
|
| Market Split by Application |
|
| Market Split by Technology |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Molecular Diagnostic industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Molecular Diagnostic Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Molecular Diagnostic Market Report Description
Introduction of Molecular Diagnostic
Molecular diagnostics is the process of collecting various techniques to analyze the biological markers in the genome and proteome. It is a laboratory procedure that helps to understand and identify a disease or its risk involved. For example, in a disease like cancer, molecular diagnostics helps in the study of DNA, RNA, and proteins in the given biological sample. Molecular diagnostics includes various tests like the polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and Fluorescence hybridization. Molecular diagnostics finds its applications in infectious disease, oncology, genetic testing, blood screening, and others. Due to the increasing prevalence of cancer or infectious diseases and the growing technological advancements, the demand for the molecular diagnostics market is expected to grow in the upcoming years.
Factors Affecting Molecular Diagnostic Market Growth
-
Increasing prevalence of cancer
The rise in cancer cases causes a significant impact globally. It accounts for the mortality rate across the globe and the growing technological markets encourage physicians to emphasize greatly on its treatment and prevention. As reported by World Health Organization (WHO), it is estimated that 10 million deaths have occurred globally in 2020. However, cancer mortality is higher in underdeveloped countries due to the late detection of the cancer stage and lack of access to treatments. According to GLOBACAN 2020, the number of cancer cases was estimated to rise to 37.5 million among the population. The biomarkers in the treatment of cancer allow the identification of genes, proteins, and tumors which indirectly provides information about the type of cancer that occurred. This is also called genomic profiling. Thus, growth in the biomarkers for cancer diagnostics and treatment increases the demand for the molecular diagnostics market. Therefore, rising cancer cases enhance the adoption of the molecular diagnostics process for early detection and treatment. However, this growing awareness of cancer diagnostics integrated with technological advancements further drives the market growth of the molecular diagnostics market.
The Restraining Factor of Molecular Diagnostic:
-
Lack of skilled professionals
The lack of skilled professionals is a major factor in the molecular diagnostics market. Diagnostic laboratories and research institutions play a very significant role in this segment. It is important for the safety, accuracy, and timeliness of the diagnostics process. Moreover, a lack of awareness about molecular diagnostics in healthcare institutions and laboratories leads to false positive reports. Healthcare institutions need to train people about the rising technological advancements and help them to adopt these techniques for the diagnostics process. For instance, Roche launched Cobas5800, a new molecular diagnostics system that provided efficient, simplified, and timely results to laboratories and also expanded its access to effective testing and improved patient care. Thus, the lack of skilled professionals and technicians can hinder the growth of the molecular diagnostics market.
Impact of the COVID-19 Pandemic on the Molecular Diagnostics Market:
The COVID-19 pandemic had adversely affected the molecular diagnostics market. The spread of COVID-19 drastically increased the number of infectious cases. Molecular testing was carried out due to viral transmission for early detection and treatment of disease. This led to a shortage of molecular testing reagents across the globe. In the regions like emerging and low-middle-income countries, there was a huge supply issue of molecular reagents. The increasing number of COVID-19 cases highly demanded diagnostic centers for providing better access and precise diagnostic results with delivering patient care and controlling viral transmissions. Therefore, this rising necessity for diagnosis lead to a shortage of PCR instruments and reagents & kits. Thus, the molecular diagnostics market had been adversely impacted due to a lack of product and instrument supply but due to rising government initiatives the molecular diagnostics market is expected to grow during the forecasted period.
We have various report editions of Molecular Diagnostic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Molecular Diagnostic Market Insights Video
Molecular Diagnostic Market News
In March 2023
- Oxford Gene Technology launched eight of its Cytocellfluorescence in-situ hybridization probe.
The Cytocellfluorescence in-situ hybridization probe got certified for clinical use in the line with InVitro Diagnostics Regulation (IVDR) in Europe. This played a major role in the management of patients with hematological cancers and prenatal conditions.
In June 2022
- Roche launched Cobas 5800, a new molecular diagnostic system to expand access to testing and improve patient care.
The Cobas 5800 system for molecular diagnostics provided efficient, simplified, and timely results to laboratories and also expanded its access to effective testing and improved patient care. It helped the laboratories to face the challenge of increasing patient testing and reimbursement complexities.
Top Companies Market Share in Molecular Diagnostic Industry: (In no particular order of Rank)
- Abbott Laboratories
- Qiagen Inc
- Biomérieux Sa
- Siemens Ag
- Danaher Corporation
- Becton Dickinson and Company
- Grifols S.A
- F. Hoffman La-Roche Ltd
- Hologic Inc.
- Agilent Technologies Inc
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America Molecular Diagnostic Market is expected to dominate the Molecular Diagnostics Market during the forecast period.
Globally, the Molecular Diagnostics Market based on region is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The largest market share is dominated by North America due to the rising prevalence of cancer in this region and the increasing number of infectious diseases. As reported in the statistics, by the Government of Canada, about 229,100 people in Canada were diagnosed with cancer. The rising burden of cancer majorly needed early-stage diagnostics and treatment. According to the Centers for Diseases Control and Prevention, respiratory syncytial virus (RSV) infections had led to more than 60,000 patients hospitalized in the U.S. annually. Thus, advancement in molecular diagnosis will continue to increase the speed and precision of the test where microbial pathogens are easily identifiable. Also, the rising innovation in technologies and healthcare systems in this region has significantly enhanced modified drugs for the treatment of cancer. Hence, drives the growth of the molecular diagnostics market.
The current report Scope analyzes Molecular Diagnostic Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Molecular Diagnostic Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Molecular Diagnostic Market Analysis
Global Molecular Diagnostic Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Molecular Diagnostic Industry growth. Molecular Diagnostic market has been segmented with the help of its Product, Application Technology, and others. Molecular Diagnostic market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Molecular Diagnostic, By Product
The reagents segment is expected to hold the market share from the years 2023-2030
Based on product, the global molecular diagnostics market is classified into instruments, reagents, and software & services. The reagents segment is expected to hold the largest market share due to its wide application in clinical research and different therapeutic areas. Reagents are those components that analyze and generate accurate results of the sample under-diagnosis. They include specific kits for pathogen screening and infectious disease diagnosis. Due to the application of standard reagents, the molecular diagnosis process is enhanced and its efficiency is improved. For instance, Roche launched Cobas5800, a new molecular diagnostics system that provided efficient, simplified, and timely results to laboratories and also expanded its access to effective testing and improved patient care. Reagents offer specificity, higher sensitivity, and automation capabilities. They also help in the research and diagnostics of cancer and other infectious disease and are also cost-effective and easy to use. Such benefits of reagents drive the growth of the molecular diagnostic market.
- Instruments
- Reagents
- Software & Services
Molecular Diagnostic Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Molecular Diagnostic Industry. Request a Free Sample PDF!
Molecular Diagnostic, By Application
The oncology segment is expected to gain the largest market share during the forecast period.
Globally, the molecular diagnostics market based on application is classified into infectious disease, oncology, genetic testing, and blood screening. The oncology segment is expected to gain the largest market share due to the increasing prevalence of cancer. The growing technological advancements in the oncology segment encourage physicians to emphasize greatly on its treatment and prevention. As reported by World Health Organization (WHO), it is estimated that 10 million deaths have occurred globally in 2020. Hence, the rise in the prevalence of cancer cases requires personalized medicines for its treatment and diagnosis. According to GLOBACAN 2020, the number of cancer cases was estimated to rise to 37.5 million among the population. Therefore, rising cancer cases enhance the adoption of the molecular diagnostics process for early detection and treatment. However, this growing awareness of cancer diagnostics integrated with technological advancements further drives the market growth of molecular diagnosis.
- Infectious Disease
- Oncology
- Genetic Testing
- Blood Screening
Molecular Diagnostic Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Molecular Diagnostic Technology Segment Analysis
Molecular Diagnostic, By Technology
The polymerase chain reaction (PCR) segment is anticipated to witness the highest market share during the forecast period.
The molecular diagnostic market, based on the technology segment is classified into polymerase chain reaction (PCR), DNA sequencing, hybridization, isothermal nucleic acid amplification technology (INNAT), DNA microarray, and in-situ hybridization The polymerase chain reaction (PCR) segment is having the highest market share due to their higher level of amplification with the simultaneous detection of pathogen DNA. The PCR technique has a wide range of applications in the research and healthcare sectors. Moreover, the growing advancements in the automation of PCR instruments like the qRT-PCR are contributing to the increase in market share of the molecular diagnostics market. PCR finds wide scope in the DNA sequencing process and is integrally linked to drug discovery and novel drug development. The PCR market is expected to grow with the development of portable real-time PCR machines and their application in an assay for point-of-care (PoC) infectious diseases diagnostics. Therefore, the emergence of advanced technology in the PCR technique is expected to propel the market of molecular diagnostics market.
- Polymerase Chain Reaction (PCR)
- DNA Sequencing
- Hybridization
- Isothermal Nucleic Acid Amplification Technology (INNAT)
- DNA Microarray
- In-Situ Hybridization
Molecular Diagnostic End User Segment Analysis
- Diagnostic Laboratories
- Hospitals
Author's Detail
Manoj PhagareSenior Research Analyst at Cognitive Market Research
• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.
Manoj Phagare is a dynamic and results-driven research analyst with a passion for transforming raw data into actionable insights. Armed with a solid foundation in market research and data analysis and working in various domains including chemical & materials and paints & coatings. He thrive on the challenge of uncovering patterns, trends, and opportunities that drive strategic decision-making.His analytical mindset, coupled with effective communication skills, allows him to bridge the gap between data analysis and practical business applications.
In his current role, Manoj is a key player in market research and competitive analysis. He have a proven track record of synthesizing disparate data sources, employing statistical models, and delivering comprehensive insights. He have played a pivotal role in shaping evidence-based strategies that fueled the success of key business initiatives and Collaborating with cross-functional teams.Manoj remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Molecular Diagnostic Market is witnessing significant growth in the near future.
In 2023, the Instruments segment accounted for noticeable share of global Molecular Diagnostic Market and is projected to experience significant growth in the near future.
The Infectious Disease segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories , Biomérieux Sa and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Molecular Diagnostic Market
Sources from Chemical & Materials Industry
- https://www.acauk.org/
- https://www.americanchemistry.com/
- https://bama.co.uk/
- https://www.basa.uk.com/
- https://www.bceca.org.uk/
- https://coatings.org.uk/?
- https://www.bpf.co.uk/
- https://www.chemical.org.uk/
- https://www.chcs.org.uk/
- https://www.cia.org.uk/
- https://www.ctpa.org.uk/
- https://www.gpca.org.ae/
- https://www.icheme.org/
- https://www.iccta.org/
- https://www.raci.org.au/home
- https://www.rsc.org/
- https://www.soci.org/
- https://www.socma.org/
- https://www.wermac.org/materials/chemical_elements.html
- https://www.rsc.org/journals-books-databases/about-journals/industrial-chemistry-materials/
- https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Archive:Chemicals_production_statistics
- https://pubs.acs.org/
- https://www.bls.gov/ooh/life-physical-and-social-science/chemists-and-materials-scientists.htm
- https://www.osha.gov/chemical-hazards
- https://www.ilo.org/global/topics/labour-administration-inspection/resources-library/publications/guide-for-labour-inspectors/harmful-chemical-and-biological-agents-substances/lang--en/index.htm
- https://www.americanchemistry.com/chemistry-in-america/data-industry-statistics
- https://www.nsf.gov/news/classroom/chemistry.jsp
- https://cen.acs.org/
- https://www.materialstoday.com/materials-chemistry/news/
- https://group.echemi.com/en/index.html
- https://www.technology.org/category/technologies/chemistry/
- https://www.cisa.gov/sites/default/files/publications/Chemical-Sector-Profile_Final%20508.pdf
Molecular Diagnostic Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Instruments, Reagents, Software & Services |
| Application | Infectious Disease, Oncology, Genetic Testing, Blood Screening |
| Technology | Polymerase Chain Reaction (PCR), DNA Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology (INNAT), DNA Microarray, In-Situ Hybridization |
| End User | Diagnostic Laboratories, Hospitals |
| List of Competitors | Abbott Laboratories, Qiagen Inc, Biomérieux Sa, Siemens Ag, Danaher Corporation, Becton Dickinson and Company, Grifols S.A, F. Hoffman La-Roche Ltd, Hologic Inc., Agilent Technologies Inc |
This chapter will help you gain GLOBAL Market Analysis of Molecular Diagnostic. Further deep in this chapter, you will be able to review Global Molecular Diagnostic Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Molecular Diagnostic Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Molecular Diagnostic Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Molecular Diagnostic Revenue Market Size By Region
-
-
1.3 Global Molecular Diagnostic Market Size By Product 2019 -2031
-
1.3.1 Instruments Market Size
-
1.3.2 Reagents Market Size
-
1.3.3 Software & Services Market Size
-
-
1.4 Global Molecular Diagnostic Market Size By Application 2019 -2031
-
1.4.1 Infectious Disease Market Size
-
1.4.2 Oncology Market Size
-
1.4.3 Genetic Testing Market Size
-
1.4.4 Blood Screening Market Size
-
-
1.5 Global Molecular Diagnostic Market Size By Technology 2019 -2031
-
1.5.1 Polymerase Chain Reaction (PCR) Market Size
-
1.5.2 DNA Sequencing Market Size
-
1.5.3 Hybridization Market Size
-
1.5.4 Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
1.5.5 DNA Microarray Market Size
-
1.5.6 In-Situ Hybridization Market Size
-
-
1.6 Global Molecular Diagnostic Market Size By End User for 2019 -2031
-
1.6.1 Diagnostic Laboratories Market Size
-
1.6.2 Hospitals Market Size
-
-
1.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.8 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.8.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.8.2 Global Market Revenue Split By Product
-
1.8.3 Global Market Revenue Split By Application
-
1.8.4 Global Market Revenue Split By Technology
-
1.8.5 Global Market Revenue Split By End User
-
1.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Molecular Diagnostic Market Size 2019 - 2031
-
2.1.1 North America Molecular Diagnostic Market Size By Country 2019 - 2031
-
2.1.2 North America Molecular Diagnostic Market Size by Product 2019 -2031
-
2.1.2.1 North America Instruments Market Size
-
2.1.2.2 North America Reagents Market Size
-
2.1.2.3 North America Software & Services Market Size
-
-
2.1.3 North America Molecular Diagnostic Market Size by Application 2019 -2031
-
2.1.3.1 North America Infectious Disease Market Size
-
2.1.3.2 North America Oncology Market Size
-
2.1.3.3 North America Genetic Testing Market Size
-
2.1.3.4 North America Blood Screening Market Size
-
-
2.1.4 North America Molecular Diagnostic Market Size by Technology 2019 -2031
-
2.1.4.1 North America Polymerase Chain Reaction (PCR) Market Size
-
2.1.4.2 North America DNA Sequencing Market Size
-
2.1.4.3 North America Hybridization Market Size
-
2.1.4.4 North America Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
2.1.4.5 North America DNA Microarray Market Size
-
2.1.4.6 North America In-Situ Hybridization Market Size
-
-
2.1.5 North America Molecular Diagnostic Market Size by End User 2019 -2031
-
2.1.5.1 North America Diagnostic Laboratories Market Size
-
2.1.5.2 North America Hospitals Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Molecular Diagnostic Market Size 2019 - 2031
-
3.1.1 Europe Molecular Diagnostic Market Size By Country 2019 - 2031
-
3.1.2 Europe Molecular Diagnostic Market Size by Product 2019 -2031
-
3.1.2.1 Europe Instruments Market Size
-
3.1.2.2 Europe Reagents Market Size
-
3.1.2.3 Europe Software & Services Market Size
-
-
3.1.3 Europe Molecular Diagnostic Market Size by Application 2019 -2031
-
3.1.3.1 Europe Infectious Disease Market Size
-
3.1.3.2 Europe Oncology Market Size
-
3.1.3.3 Europe Genetic Testing Market Size
-
3.1.3.4 Europe Blood Screening Market Size
-
-
3.1.4 Europe Molecular Diagnostic Market Size by Technology 2019 -2031
-
3.1.4.1 Europe Polymerase Chain Reaction (PCR) Market Size
-
3.1.4.2 Europe DNA Sequencing Market Size
-
3.1.4.3 Europe Hybridization Market Size
-
3.1.4.4 Europe Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
3.1.4.5 Europe DNA Microarray Market Size
-
3.1.4.6 Europe In-Situ Hybridization Market Size
-
-
3.1.5 Europe Molecular Diagnostic Market Size by End User 2019 -2031
-
3.1.5.1 Europe Diagnostic Laboratories Market Size
-
3.1.5.2 Europe Hospitals Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Molecular Diagnostic Market Size 2019 - 2031
-
4.1.1 Asia Pacific Molecular Diagnostic Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Molecular Diagnostic Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Instruments Market Size
-
4.1.2.2 Asia Pacific Reagents Market Size
-
4.1.2.3 Asia Pacific Software & Services Market Size
-
-
4.1.3 Asia Pacific Molecular Diagnostic Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Infectious Disease Market Size
-
4.1.3.2 Asia Pacific Oncology Market Size
-
4.1.3.3 Asia Pacific Genetic Testing Market Size
-
4.1.3.4 Asia Pacific Blood Screening Market Size
-
-
4.1.4 Asia Pacific Molecular Diagnostic Market Size by Technology 2019 -2031
-
4.1.4.1 Asia Pacific Polymerase Chain Reaction (PCR) Market Size
-
4.1.4.2 Asia Pacific DNA Sequencing Market Size
-
4.1.4.3 Asia Pacific Hybridization Market Size
-
4.1.4.4 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
4.1.4.5 Asia Pacific DNA Microarray Market Size
-
4.1.4.6 Asia Pacific In-Situ Hybridization Market Size
-
-
4.1.5 Asia Pacific Molecular Diagnostic Market Size by End User 2019 -2031
-
4.1.5.1 Asia Pacific Diagnostic Laboratories Market Size
-
4.1.5.2 Asia Pacific Hospitals Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Molecular Diagnostic Market Size 2019 - 2031
-
5.1.1 South America Molecular Diagnostic Market Size By Country 2019 - 2031
-
5.1.2 South America Molecular Diagnostic Market Size by Product 2019 -2031
-
5.1.2.1 South America Instruments Market Size
-
5.1.2.2 South America Reagents Market Size
-
5.1.2.3 South America Software & Services Market Size
-
-
5.1.3 South America Molecular Diagnostic Market Size by Application 2019 -2031
-
5.1.3.1 South America Infectious Disease Market Size
-
5.1.3.2 South America Oncology Market Size
-
5.1.3.3 South America Genetic Testing Market Size
-
5.1.3.4 South America Blood Screening Market Size
-
-
5.1.4 South America Molecular Diagnostic Market Size by Technology 2019 -2031
-
5.1.4.1 South America Polymerase Chain Reaction (PCR) Market Size
-
5.1.4.2 South America DNA Sequencing Market Size
-
5.1.4.3 South America Hybridization Market Size
-
5.1.4.4 South America Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
5.1.4.5 South America DNA Microarray Market Size
-
5.1.4.6 South America In-Situ Hybridization Market Size
-
-
5.1.5 South America Molecular Diagnostic Market Size by End User 2019 -2031
-
5.1.5.1 South America Diagnostic Laboratories Market Size
-
5.1.5.2 South America Hospitals Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Molecular Diagnostic Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Molecular Diagnostic Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Molecular Diagnostic Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Instruments Market Size
-
6.1.2.2 Middle East and Africa Reagents Market Size
-
6.1.2.3 Middle East and Africa Software & Services Market Size
-
-
6.1.3 Middle East and Africa Molecular Diagnostic Market Size by Application 2019 -2031
-
6.1.3.1 Middle East and Africa Infectious Disease Market Size
-
6.1.3.2 Middle East and Africa Oncology Market Size
-
6.1.3.3 Middle East and Africa Genetic Testing Market Size
-
6.1.3.4 Middle East and Africa Blood Screening Market Size
-
-
6.1.4 Middle East and Africa Molecular Diagnostic Market Size by Technology 2019 -2031
-
6.1.4.1 Middle East and Africa Polymerase Chain Reaction (PCR) Market Size
-
6.1.4.2 Middle East and Africa DNA Sequencing Market Size
-
6.1.4.3 Middle East and Africa Hybridization Market Size
-
6.1.4.4 Middle East and Africa Isothermal Nucleic Acid Amplification Technology (INNAT) Market Size
-
6.1.4.5 Middle East and Africa DNA Microarray Market Size
-
6.1.4.6 Middle East and Africa In-Situ Hybridization Market Size
-
-
6.1.5 Middle East and Africa Molecular Diagnostic Market Size by End User 2019 -2031
-
6.1.5.1 Middle East and Africa Diagnostic Laboratories Market Size
-
6.1.5.2 Middle East and Africa Hospitals Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Molecular Diagnostic Market Size by Product 2019 -2031
-
7.1.2 Country 1Molecular Diagnostic Market Size by Application 2019 -2031
-
7.1.3 Country 1Molecular Diagnostic Market Size by Technology 2019 -2031
-
7.1.4 Country 1Molecular Diagnostic Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Molecular Diagnostic Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Qiagen Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Biomérieux Sa
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Siemens Ag
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Danaher Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Becton Dickinson and Company
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Grifols S.A
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 F. Hoffman La-Roche Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Hologic Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Agilent Technologies Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Instruments
-
10.1.1 Global Molecular Diagnostic Revenue Market Size and Share by Instruments 2019 -2031
-
-
10.2 Reagents
-
10.2.1 Global Molecular Diagnostic Revenue Market Size and Share by Reagents 2019 -2031
-
-
10.3 Software & Services
-
10.3.1 Global Molecular Diagnostic Revenue Market Size and Share by Software & Services 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Infectious Disease
-
11.1.1 Global Molecular Diagnostic Revenue Market Size and Share by Infectious Disease 2019 - 2031
-
-
11.2 Oncology
-
11.2.1 Global Molecular Diagnostic Revenue Market Size and Share by Oncology 2019 - 2031
-
-
11.3 Genetic Testing
-
11.3.1 Global Molecular Diagnostic Revenue Market Size and Share by Genetic Testing 2019 - 2031
-
-
11.4 Blood Screening
-
11.4.1 Global Molecular Diagnostic Revenue Market Size and Share by Blood Screening 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Technology Analysis 2019 -2031
-
12.1 Polymerase Chain Reaction (PCR)
-
12.1.1 Global Molecular Diagnostic Revenue Market Size and Share by Polymerase Chain Reaction (PCR) 2019 -2031
-
-
12.2 DNA Sequencing
-
12.2.1 Global Molecular Diagnostic Revenue Market Size and Share by DNA Sequencing 2019 -2031
-
-
12.3 Hybridization
-
12.3.1 Global Molecular Diagnostic Revenue Market Size and Share by Hybridization 2019 -2031
-
-
12.4 Isothermal Nucleic Acid Amplification Technology (INNAT)
-
12.4.1 Global Molecular Diagnostic Revenue Market Size and Share by Isothermal Nucleic Acid Amplification Technology (INNAT) 2019 -2031
-
-
12.5 DNA Microarray
-
12.5.1 Global Molecular Diagnostic Revenue Market Size and Share by DNA Microarray 2019 -2031
-
-
12.6 In-Situ Hybridization
-
12.6.1 Global Molecular Diagnostic Revenue Market Size and Share by In-Situ Hybridization 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End User Analysis 2019 -2031
-
13.1 Diagnostic Laboratories
-
13.1.1 Global Molecular Diagnostic Revenue Market Size and Share by Diagnostic Laboratories 2019 -2031
-
-
13.2 Hospitals
-
13.2.1 Global Molecular Diagnostic Revenue Market Size and Share by Hospitals 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Molecular Diagnostic market
Chapter 14 Research Findings
-
14.1 Key Takeaways
-
14.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
14.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manoj Phagare and Team
- 1.1 Molecular Diagnostic Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Molecular Diagnostic Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Molecular Diagnostic Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Molecular Diagnostic Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Molecular Diagnostic Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Molecular Diagnostic Market
Key Questions Answered By Molecular Diagnostic Market Report 2024
| Why Instruments have a significant impact on Molecular Diagnostic market? |
| What are the key factors affecting the Instruments and Reagents of Molecular Diagnostic Market? |
| What is the CAGR/Growth Rate of Infectious Disease during the forecast period? |
| By type, which segment accounted for largest share of the global Molecular Diagnostic Market? |
| Which region is expected to dominate the global Molecular Diagnostic Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
